We examine how real-world evidence strategies help address uncertainties in rare disease treatments ...
Read moreWe've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreHope that new action plan and collaboration with the rare diseases community will progress positive ...
Read moreWe've prepared an analysis of the top 10 most expensive drugs in the US compared with Germany, in th...
Read moreThe company found themselves facing competitive tenders for the first time in this disease space - t...
Read moreDigitisation is thought to contribute significant improvements in knowledge generation in drug devel...
Read moreThey came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...
Read moreThe study looks at the direct, indirect and mortality-related costs of 24 rare diseases across five ...
Read moreOn 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...
Read moreInnovative therapies for rare diseases may only be available in a select number of countries in Euro...
Read more